Holen Sie sich die Stockscreener-App
1.29
0.00%
0.00
Schlusskurs vom Vortag:
$1.29
Offen:
$1.31
24-Stunden-Volumen:
9,353
Relative Volume:
0.01
Marktkapitalisierung:
$5.89M
Einnahmen:
$9.37M
Nettoeinkommen (Verlust:
$-8.45M
KGV:
-1.5926
EPS:
-0.81
Netto-Cashflow:
$-7.27M
1W Leistung:
+5.74%
1M Leistung:
-22.29%
6M Leistung:
-87.35%
1J Leistung:
-95.33%
1-Tages-Spanne:
$1.30
$1.32
1-Wochen-Bereich:
$1.2301
$1.47
52-Wochen-Spanne:
$1.1101
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Firmenname
Bioaffinity Technologies Inc
Sektor
Branche
Telefon
210-698-5334
Adresse
3300 NACOGDOCHES ROAD, SAN ANTONIO
Vergleichen Sie BIAF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
1.31 | 5.80M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
610.28 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.44 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
709.20 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.41 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
244.87 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
Will bioAffinity Technologies Inc. stock outperform tech sector in 20252025 Earnings Surprises & Low Risk Profit Maximizing Plans - ulpravda.ru
Is bioAffinity Technologies Inc. Equity Warrant stock cheap compared to fundamentalsJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - ulpravda.ru
Will bioAffinity Technologies Inc. stock pay special dividendsJuly 2025 Sector Moves & Low Risk High Win Rate Picks - ulpravda.ru
Can bioAffinity Technologies Inc. Equity Warrant stock sustain revenue growth2025 Key Lessons & Weekly Momentum Picks - ulpravda.ru
Can bioAffinity Technologies Inc. stock maintain growth trajectoryWeekly Market Summary & Detailed Earnings Play Strategies - ulpravda.ru
Will bioAffinity Technologies Inc. stock attract ESG investorsWeekly Trade Summary & Stock Timing and Entry Methods - ulpravda.ru
Will bioAffinity Technologies Inc. Equity Warrant stock attract ESG investors2025 Fundamental Recap & Daily Chart Pattern Signals - ulpravda.ru
Is bioAffinity Technologies Inc. stock trading at a premium valuationJuly 2025 Final Week & Weekly Watchlist for Consistent Profits - ulpravda.ru
How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peersFundamental Stock Analysis & Small Entry Cost Stocks - ulpravda.ru
bioAffinity Labs Maintain CAP Accreditation, Supporting CyPath Lung - TipRanks
bioAffinity Technologies Maintains CAP Accreditation - TradingView — Track All Markets
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation - Business Wire
2026 world cup star players explained: How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peers2026 world cup usa national team round of 32 playmakers low block defense odds analysis preview - ulpravda.ru
bioAffinity Adjourns Special Stockholder Meeting for Lack Quorum - MSN
bioAffinity Technologies Inc. (BIAF) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 10.8% – Here’s What Happened - Defense World
bioAffinity Technologies (NASDAQ:BIAF) Stock Price Down 4.9% – Here’s What Happened - Defense World
What drives bioAffinity Technologies Inc Equity Warrant stock priceMarket Liquidity Analysis & High Yield Market Growth - earlytimes.in
Bearish Setup: Will bioAffinity Technologies Inc stock pay special dividendsCPI Data & Weekly Momentum Stock Picks - moha.gov.vn
bioAffinity Technologies reports transfer of Village Oaks Pathology ownership By Investing.com - Investing.com Nigeria
bioAffinity Technologies reports transfer of Village Oaks Pathology ownership - Investing.com
bioAffinity Updates Village Oaks Physician Succession Agreement - TipRanks
bioAffinity Technologies Announces Succession Agreement - TradingView — Track All Markets
Is bioAffinity Technologies Inc. stock a defensive play in 2025Trade Volume Summary & Community Trade Idea Sharing Platform - Улправда
Energy Moves: How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peers2025 Technical Overview & Free Fast Gain Swing Trade Alerts - Улправда
Will bioAffinity Technologies Inc. stock return to pre crisis levelsJuly 2025 Setups & Free Long-Term Investment Growth Plans - Улправда
Nasdaq Moves: Why bioAffinity Technologies Inc. stock could be next big winnerQuarterly Trade Report & Community Verified Watchlist Alerts - moha.gov.vn
How bioAffinity Technologies Inc. Equity Warrant stock trades during market volatilityJuly 2025 Chart Watch & Free Verified High Yield Trade Plans - Улправда
bioAffinity Technologies Earnings Notes - Trefis
Will bioAffinity Technologies Inc. Equity Warrant stock deliver strong dividend growthWeekly Stock Summary & Real-Time Market Sentiment Reports - Улправда
Market Catalysts: Is bioAffinity Technologies Inc. stock a defensive play in 2025Weekly Investment Recap & Safe Investment Capital Preservation Plans - Улправда
bioAffinity Technologies adjourns special shareholder meeting due to lack of quorum - Investing.com Nigeria
bioAffinity Technologies adjourns special shareholder meeting due to lack of quorum By Investing.com - Investing.com South Africa
Why bioAffinity Technologies Inc. Equity Warrant stock appeals to dividend seekers2025 Pullback Review & Fast Entry Momentum Trade Alerts - Улправда
bioAffinity Technologies Adjourns Special Meeting - TradingView — Track All Markets
New Highs: Why bioAffinity Technologies Inc. stock could be next big winner - Улправда
Rate Hike: Can bioAffinity Technologies Inc. stock maintain growth trajectoryQuarterly Risk Review & Free High Accuracy Swing Entry Alerts - DonanımHaber
Is bioAffinity Technologies Inc. Equity Warrant stock dividend yield sustainablePortfolio Return Summary & Advanced Technical Analysis Signals - DonanımHaber
Trading Recap: Can bioAffinity Technologies Inc. Equity Warrant stock sustain revenue growthInsider Buying & AI Forecasted Stock Moves - DonanımHaber
Why bioAffinity Technologies Inc. stock could be next big winnerWeekly Investment Report & Smart Investment Allocation Insights - Улправда
What catalysts could drive bioAffinity Technologies Inc. Equity Warrant stock higherJuly 2025 Movers & Daily Volume Surge Trade Alerts - Улправда
bioAffinity Technologies, Inc. (BIAFW) Fundamental Analysis - Meyka
Reviewing bioAffinity Technologies (NASDAQ:BIAF) and Briacell Therap (NASDAQ:BCTX) - Defense World
Why bioAffinity Technologies Inc. stock could outperform in 2025Trade Risk Assessment & Growth Oriented Trading Recommendations - Newser
BIAF Stock Dips After Q3 Earnings Reflect Lower Sales and Wider Loss - MSN
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society - PharmiWeb.com
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable - BioSpace
bioAffinity Technologies to Present at Cancer Roundtable - TipRanks
bioAffinity Technologies, Inc. to Present CyPath® Lung Test at ACS Roundtable - TradingView
Certain Warrants of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
Certain Convertible Preferred Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.20%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):